Summary
Procter & Gamble's (PG) fiscal year 2020 10-K filing highlights a strong year with net sales increasing by 5% to $71.0 billion, driven by a 4% rise in unit volume. The company demonstrated significant operational improvement, with operating income soaring by 186% primarily due to the absence of prior year impairment charges, and net earnings attributable to Procter & Gamble growing by 234% to $13.0 billion. Diluted EPS saw a substantial increase of 247% to $4.96, with Core EPS growing a healthy 13% to $5.12. The company effectively managed its diverse product portfolio, with notable performance in Fabric & Home Care and Health Care segments showing strong sales and earnings growth. The COVID-19 pandemic had mixed effects, leading to increased demand for hygiene and cleaning products, while impacting certain discretionary categories and international markets. P&G successfully navigated these challenges, maintaining operational continuity and demonstrating resilience. The company also continued its commitment to shareholder returns, increasing its dividend and repurchasing shares. Key risks highlighted include international operations volatility, economic uncertainties, supply chain disruptions, and the ongoing need for innovation and adaptation to changing consumer habits and competitive landscapes. The company's strong liquidity position, supported by robust operating cash flow and access to credit markets, underpins its ability to manage these risks and pursue its strategic objectives.
Financial Highlights
57 data points| Revenue | $70.95B |
| Cost of Revenue | $35.25B |
| Gross Profit | $35.70B |
| R&D Expenses | $1.80B |
| SG&A Expenses | $19.99B |
| Operating Income | $15.71B |
| Interest Expense | $465.00M |
| Net Income | $13.03B |
| EPS (Basic) | $5.13 |
| EPS (Diluted) | $4.96 |
| Shares Outstanding (Basic) | 2.49B |
| Shares Outstanding (Diluted) | 2.63B |
Key Highlights
- 1Net sales increased by 5% to $71.0 billion, with unit volume up 4%.
- 2Operating income increased by 186% to $15.7 billion, largely due to a significant reduction in prior year impairment charges.
- 3Net earnings attributable to Procter & Gamble increased by 234% to $13.0 billion.
- 4Diluted EPS rose by 247% to $4.96, while Core EPS grew by 13% to $5.12.
- 5Fabric & Home Care and Health Care segments showed strong sales and earnings growth.
- 6The company successfully managed the impacts of the COVID-19 pandemic, which led to increased demand for certain products while impacting others.
- 7P&G increased its dividend by 6% and completed $7.4 billion in share repurchases during fiscal year 2020.